USP2 and precursor B-cell acute lymphoblastic leukemia: Interestingly, wild-type USP2 was not transcribed in majority of B-ALL patients (Figure 4A) and could be activated through fusion with KMT2A (Figure 4B), with active transcription of USP2 occurring through hijacking of the KMT2A promoter (Supplementary Figure 3).